doi: 10.1089/aid.1994.10.331.
Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine
- PMID: 8068412
- DOI: 10.1089/aid.1994.10.331
Item in Clipboard
Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine
AIDS Res Hum Retroviruses.
1994 Apr.
No abstract available
Similar articles
-
Live HIV vaccines--how safe?Nat Med. 1997 Aug;3(8):816. doi: 10.1038/nm0897-816b. Nat Med. 1997. PMID: 9256262 No abstract available.
-
Live attenuated AIDS viruses as vaccines: promise or peril?Immunol Rev. 1999 Aug;170:135-49. doi: 10.1111/j.1600-065x.1999.tb01335.x. Immunol Rev. 1999. PMID: 10566148 Review.
-
HIV with multiple gene deletions as a live attenuated vaccine for AIDS.AIDS Res Hum Retroviruses. 1992 Aug;8(8):1457. doi: 10.1089/aid.1992.8.1457. AIDS Res Hum Retroviruses. 1992. PMID: 1466981 No abstract available.
-
Attenuated HIV vaccine: caveats.Science. 1996 Mar 29;271(5257):1790-2. Science. 1996. PMID: 8596941 No abstract available.
-
Live attenuated HIV vaccines: pitfalls and prospects.Curr Opin Infect Dis. 2004 Feb;17(1):17-26. doi: 10.1097/00001432-200402000-00004. Curr Opin Infect Dis. 2004. PMID: 15090885 Review.
Cited by
-
Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.J Virol. 2001 May;75(9):4430-4. doi: 10.1128/JVI.75.9.4430-4434.2001. J Virol. 2001. PMID: 11287595 Free PMC article.
-
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.J Virol. 2002 Jul;76(14):7187-202. doi: 10.1128/jvi.76.14.7187-7202.2002. J Virol. 2002. PMID: 12072518 Free PMC article. Clinical Trial.
-
Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies.J Virol. 1996 Jan;70(1):617-22. doi: 10.1128/JVI.70.1.617-622.1996. J Virol. 1996. PMID: 8523581 Free PMC article.
-
Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon.J Virol. 1996 Apr;70(4):2247-51. doi: 10.1128/JVI.70.4.2247-2251.1996. J Virol. 1996. PMID: 8642649 Free PMC article.
-
Immunogenicity of a lentiviral-based DNA vaccine driven by the 5'LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques.Vaccine. 2012 Apr 19;30(19):2956-62. doi: 10.1016/j.vaccine.2012.02.050. Epub 2012 Mar 2. Vaccine. 2012. PMID: 22387218 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
